Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
One study published in the New England Journal of Medicine in 2017 found that semaglutide was associated with a significant reduction in blood pressure compared to placebo in individuals with type 2 diabetes
Common initial side effects include mild nausea, constipation, and reduced appetite, which typically resolve within 24 weeks
From this model, the direct effect of semaglutide versus placebo on eGFR (hence, independent of change in body weight) was estimated
Track GLP-1 prescribing trends with all-payer claims data As research into GLP-1s continue to expand the indications for this therapy, payer and employer coverage policies will keep evolving alongside patient behavior
US$ 24.96
US$ 24.00
US$ 29.08
US$ 20.77
US$ 23.59
US$ 21.94
US$ 28.76
US$ 20.39
US$ 22.36
US$ 24.72
US$ 21.67
